Search results

Creoptix focuses on next-generation bioanalytical instruments for drug discovery and life sciences for both industry and academic research. Creoptix was acquired by Malvern Panalytical in 2022.

Cell Culture Technologies is an independent and privately funded Swiss biotech company specialised in the development and application of in vitro cell culture for the production of cells and biotherapeutics in fully synthetic, chemically defined culture environments.

Our bioreactors enable the growth of 3D living tissues for tissue development, drug testing, and organ regeneration. The U-CUP perfusion bioreactor helps with 3D cell and tissue culture establishment and control, including organotypic models and cell expansion/differentiation.

CePower GmbH is a specialized laboratory for the generation and production of monoclonal antibodies. Different cell culture systems and cell lines are available for customers projects.

CARBOGEN AMCIS is a leading provider of drug development and commercialization services to pharmaceutical and biopharmaceutical companies across all development stages.

Biotech Concepts Ltd. is focused on biotech processes and process development consultancy. The development of anti-infective substances for novel drug targets and targeting approaches, thereby contribute to solve the unmet medical needs in combating (recurring) infectious diseases is a second area.

The group, offering state-of-the-art regenerative medicine solutions, has developed a technology platform that gave birth to therapies aiming at tissue regeneration across different applications, in order to provide pertinent and sustainable solutions leveraging the human's natural endowment.

BMA is a Swiss biotech founded by immunologists, developing and commercializing antibodies and ELISA kits for in-vitro research. It offers monoclonal and polyclonal antibodies made with serum-free media, supporting sustainability, reproducibility, and applications from cancer to infectious diseases.

Since 1982, BIOREBA has been an independent biotech company offering diagnostic tests such as ELISA or PCR for serological and molecular analysis of plant pathogens. Our high quality products are available worldwide. BIOREBA is ISO 9001 and ISO/IEC 17025 certified for plant pathogen analysis.

The BCC is a unique facility based in Fribourg, Switzerland, that provides services and research collaborations for the development of biopharmaceutical bioprocesses, as well as theoretical and practical training courses at all levels to the biopharmaceutical industry;

Biognosys provides next generation proteomics technology to quantify thousands of proteins for biomarker discovery or mode of action studies. The technology is available to researchers worldwide through our contract research services or our innovative reagent and software products. Biognosys was acquired by B

Biolytix is headquartered in Switzerland and aims to be a leading partner for microbiological and molecular biology analyzes. Biolytix works with clients in all major international markets and strives to have a leading position in its core competencies.

Development, production and commercialization of biological plant protection products.

In its work to further the AO Foundation's mission, AO Research Institute Davos's purpose is to advance orthopedic patient care through innovative research and development.

AlloCyte Pharmaceuticals AG is a Swiss-based company discovering, developing and commercializing next generation oral integrin modulators of allosteric mode of action protecting the integrity of tissues afflicted by autoimmunity. The next target milestone is clinical therapeutic proof-of-concept.

AGINKO Research is a premiere CRO for preclinical work in osteoarticular pathologies. We offer a wide range of contract research services to support drug and medical device established companies as well as start-ups and academia.

4D Lifetec has developed an easy-to-use blood test consisting of a patented RO platform technology and a proprietary immuno-biomarker to detect DNA degradation early. A protected AI enables high-throughput analysis. The assay successfully passed first clinical documentation for both oncology and longevity app

ABAC‘s objective are low intervention, low waste and bioavailability enhancing process inventions for providing consumers with beneficial active food ingredients.

Abionic has developed a revolutionary nanofluidic technology providing professionals a unique and ultra-fast point of care diagnostic tool allowing immediate access to results for a large panel of blood tests. Abionic has developed the fastest sepsis test to identify people at risk to develop sepsis.